Design Therapeutics, Inc. has been removed from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.93 USD | +2.08% | -2.48% | +48.30% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.30% | 223M | |
+52.36% | 58.06B | |
-3.86% | 40.53B | |
+38.14% | 38.99B | |
-12.01% | 26.56B | |
+14.13% | 26.7B | |
-21.62% | 18.98B | |
+0.21% | 12.17B | |
+25.96% | 11.92B | |
+23.02% | 12B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Design Therapeutics, Inc.(NasdaqGS: DSGN) dropped from NASDAQ Biotechnology Index